COPD Therapy

Links shared publicly online about this topic

PharmaTelevision - COPD Therapies, PTV News: May 12, 2010

pharmatelevision.com — “PharmaTelevision - COPD Therapies, PTV News: May 12, 2010View full resource at pharmatelevision.com

  • View Related
  • Share

Most Recently Shared on May 12, 2010 at 12:06 pm By:

PharmaTV PharmaTelevision Pharma

COPD Therapies, PTV News: May 12, 2010: Galapagos and Roche expand their alliance to develop "smokers lung" drugs http://tinyurl.com/35m63w9

2 years ago...

Nycomed wins EU approval for COPD therapy - FierceBiotech

fiercebiotech.com — “Despite being rebuffed by the FDA and its drug experts, Switzerland's Nycomed has won EU approval for Daxas, its new therapy to treat chronic obstructive pulmonary disorder. The approval will usher... Read more...View full resource at fiercebiotech.com

  • View Related
  • Share

Most Recently Shared on July 6, 2010 at 3:31 pm By:

rlanzara Richard G. Lanzara Health Professional

RT @BiotechNews Nycomed wins EU approval for COPD therapy: Despite being rebuffed by the FDA... http://bit.ly/aFXFNj #Pharma #BioTech

2 years ago...

Novartis wins FDA OK of low-dose COPD therapy - FierceBiotech

fiercebiotech.com — “Two years after the FDA originally stiff-armed Novartis on indacaterol inhalation powder regulators finally gave the COPD treatment a green light at a low dose. Word of the approval spread late on Read more...View full resource at fiercebiotech.com

  • View Related
  • Share

Most Recently Shared on July 5, 2011 at 12:45 pm By:

FierceBiotech FierceBiotech Health News

Novartis wins FDA OK of low-dose COPD therapy. http://bit.ly/kaYv10

11 months ago...

Asthma and COPD Therapy | SYMBICORT® (budesonide/formoterol fumarate dihydrate)

symbicorttouchpoints.com — “Find information on asthma and COPD maintenance therapy with SYMBICORT (budesonide/formoterol fumarate dihydrate).View full resource at symbicorttouchpoints.com

  • View Related
  • Share

Most Recently Shared on October 8, 2010 at 3:26 pm By:

HighlightHEALTH Walter Jessen - Highlight HEALTH Health Executive and Health Organization

Symbicort (budesonide/formoterol fumarate dehydrate) [Highlight HEALTH Web Directory] http://ow.ly/19lVGt

2 years ago...

Vectura Announces A New US Collaboration Agreement With A Leading International Pharmaceutical Company for the VR315 Combination Asthma/COPD Therapy - Drugs.com MedNews

drugs.com — “Chippenham, UK 3 August 2011 - Vectura Group plc ( Vectura LSE VEC) today announces that it has signed a US collaboration, development and license agreement witView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 3, 2011 at 5:14 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Vectura Announces A New US Collaboration Agreement With A Leading International Pharmaceutical Company for... http://bit.ly/qUwLfb #drug

10 months ago...

ingentaconnect Triple Therapy for the Management of COPD: A Review

ingentaconnect.com — “ingentaconnect Triple Therapy for the Management of COPD: A ReviewView full resource at ingentaconnect.com

  • View Related
  • Share

Most Recently Shared on June 9, 2011 at 12:26 pm By:

JuanCIvancevich Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician

COPD: There is insufficient evidence to determine if triple therapy is superior to dual bronchodilator therapy http://bit.ly/kNGfkH

12 months ago...

Respiratory Therapy Cave: What is severe COPD?

respiratorytherapycave.blogspot.com — “Respiratory Therapy Cave: What is severe COPD?View full resource at respiratorytherapycave.blogspot.com

  • View Related
  • Share

Most Recently Shared on March 26, 2010 at 2:06 pm By:

Physician's Weekly Article - Antibiotic Therapy & COPD Exacerbations

physweeklyarchives.com — “Physician's Weekly, your source for medical news, information on new drugs and devices, clinical updates, CME accreditation for radiology, emergency medicine, pediatrics, mammography, and anesthesia .View full resource at physweeklyarchives.com

  • View Related
  • Share

Most Recently Shared on September 9, 2010 at 9:25 pm By:

PriMed_Alerts Pri-Med Medical Education

Antibiotic Therapy & COPD Exacerbations - A Massachusetts research group has found that early antibiotic administrat... http://ow.ly/18WgAy

2 years ago...

Medical News: Triple Therapy Reduces COPD Exacerbations - in Pulmonology, COPD from MedPage Today

medpagetoday.com — “For moderate-to-severe chronic obstructive pulmonary disease (COPD), a triple regimen of a long-acting β-agonist (LABA), an inhaled corticosteroid, and an antimuscarinic agent substantially cutsView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on October 8, 2009 at 7:21 pm By:

MedicalNews Medical News Health News

Triple Therapy Reduces COPD Exacerbations (CME/CE) http://ow.ly/15TGWI

3 years ago...

Triple-Therapy That Includes Tiotropium Reduces Death Rate in COPD

copd.about.com — “Triple-Therapy That Includes Tiotropium Reduces Death Rate in COPDView full resource at copd.about.com

  • View Related
  • Share

Most Recently Shared on August 25, 2011 at 8:54 pm By:

AboutCOPD AboutCOPD Nurse

Deborah Trendel-Lead Triple-Therapy That Includes Tiotropium Reduces Death Rate in COPD: // <![CDATA[ "> // ]]>... http://t.co/4rCP7Ff

9 months ago...

Combination Therapy Options in Stable COPD - QualityPoint Technologies

qualitypointtech.net — “Which long-acting muscarinic antagonist improves outcomes in COPD? U.S. PharmacistView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on August 20, 2010 at 4:09 pm By:

MedicalFeed MedicalFeed Health News Feed

Combination Therapy Options in Stable COPD: Which long-acting muscarinic antagonist improves outcomes in COPD? U.... http://bit.ly/bbOEAN

2 years ago...

Combination Therapy Options in Stable COPD - QualityPoint Technologies

qualitypointtech.net — “Which long-acting muscarinic antagonist improves outcomes in COPD? U.S. Pharmacist (Source: Medscape Today Headlines)View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on August 20, 2010 at 5:42 pm By:

MedicalFeed MedicalFeed Health News Feed

Combination Therapy Options in Stable COPD: Which long-acting muscarinic antagonist improves outcomes in COPD? U.S... http://bit.ly/cItCmJ

2 years ago...

Respiratory Therapy Cave: The best Asthma, COPD blogs & websites of 2010

respiratorytherapycave.blogspot.com — “Respiratory Therapy Cave: The best Asthma, COPD blogs & websites of 2010View full resource at respiratorytherapycave.blogspot.com

  • View Related
  • Share

Most Recently Shared on December 30, 2009 at 4:19 pm By:

Respiratory Therapy Cave: COPD more common than thought

respiratorytherapycave.blogspot.com — “Respiratory Therapy Cave: COPD more common than thoughtView full resource at respiratorytherapycave.blogspot.com

  • View Related
  • Share

Most Recently Shared on January 14, 2011 at 2:30 am By:

Triple Therapy Halves Exacerbations in Moderate-to-Severe COPD

newswise.com — “Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting -agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on October 8, 2009 at 5:36 am By:

mednewswise Thom Canalichio Health News

Triple Therapy Halves Exacerbations in Moderate-to-Severe COPD http://bit.ly/1sqJ6C

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • PharmaTV

    PharmaTelevision

    PharmaTelevision is the online TV channel for the pharmaceutical and biotechnology sectors, offering insights and feature interviews with industry leaders.

    View Profile

  • rlanzara

    Richard G. Lanzara

    Entrepreneurial Scientist and Pharmacologist interested in how our senses and receptors work and everything else that follows from that...

    View Profile

  • FierceBiotech

    FierceBiotech

    FierceBiotech's 140, written by Managing Editor Maureen Martino. Join the largest and most active biotech news readership in the world at FierceBiotech.com.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390